Studies of genetic syndromes, familial aggregation, linkage and mutagen sensitivity, which identified specific candidate genes including APC, hMLH1, hMSH2, PMS2, PTEN, NF1, NF2, et al, indicated the genetic susceptibility to gliomas [20–22]. This evidence concerns the gene MLH1 and central nervous system cancer.